Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

β-arrestin1 mediates metastatic growth of breast cancer cells by facilitating HIF-1-dependent VEGF expression

Oncogene volume 31, pages 282–292 (2012)Cite this article

Abstract

β-Arrestins 1 and 2 are multifunctional adaptor proteins originally discovered for their role in desensitizing seven-transmembrane receptor signaling via the heterotrimeric guanine nucleotide-binding proteins. Recently identified roles of β-arrestins include regulation of cancer cell chemotaxis and proliferation. Herein, we report that β-arrestin1 expression regulates breast tumor colonization in nude mice and cancer cell viability during hypoxia. β-Arrestin1 robustly interacts with nuclear hypoxia-induced factor-1α (HIF-1α) that is stabilized during hypoxia and potentiates HIF-1-dependent transcription of the angiogenic factor vascular endothelial growth factor-A (VEGF-A). Increased expression of β-arrestin1 in human breast cancer (infiltrating ductal carcinoma or IDC and metastatic IDC) correlates with increased levels of VEGF-A. While the anti-angiogenic drug thalidomide inhibits HIF-1-dependent VEGF transcription in breast carcinoma cells, it does not prevent HIF-1α stabilization, but leads to aberrant localization of HIF-1α to the perinuclear compartments and surprisingly stimulates nuclear export of β-arrestin1. Additionally, imatinib mesylate that inhibits release of VEGF induces nuclear export of β-arrestin1–HIF-1α complexes. Our findings suggest that β-arrestin1 regulates nuclear signaling during hypoxia to promote survival of breast cancer cells via VEGF signaling and that drugs that induce its translocation from the nucleus to the cytoplasm could be useful in anti-angiogenic and breast cancer therapies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Alvarez CJ, Lodeiro M, Theodoropoulou M, Camina JP, Casanueva FF, Pazos Y . (2009). Obestatin stimulates Akt signalling in gastric cancer cells through beta-arrestin-mediated epidermal growth factor receptor transactivation. Endocr Relat Cancer 16: 599–611.

    Article  CAS  Google Scholar 

  • Arany Z, Huang LE, Eckner R, Bhattacharya S, Jiang C, Goldberg MA et al. (1996). An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci USA 93: 12969–12973.

    Article  CAS  Google Scholar 

  • Attramadal H, Arriza JL, Aoki C, Dawson TM, Codina J, Kwatra MM et al. (1992). Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. J Biol Chem 267: 17882–17890.

    CAS  PubMed  Google Scholar 

  • Beppu K, Jaboine J, Merchant MS, Mackall CL, Thiele CJ . (2004). Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression. J Natl Cancer Inst 96: 46–55.

    Article  CAS  Google Scholar 

  • Buchanan FG, Gorden DL, Matta P, Shi Q, Matrisian LM, DuBois RN . (2006). Role of beta-arrestin 1 in the metastatic progression of colorectal cancer. Proc Natl Acad Sci USA 103: 1492–1497.

    Article  CAS  Google Scholar 

  • Chuaqui RF, Zhuang Z, Emmert-Buck MR, Liotta LA, Merino MJ . (1997). Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast. Am J Pathol 150: 297–303.

    CAS  PubMed  PubMed Central  Google Scholar 

  • D'Amato RJ, Loughnan MS, Flynn E, Folkman J . (1994). Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91: 4082–4085.

    Article  CAS  Google Scholar 

  • Daaka Y . (2004). G proteins in cancer: the prostate cancer paradigm. Sci STKE 2004: re2.

    Google Scholar 

  • Dasgupta P, Rastogi S, Pillai S, Ordonez-Ercan D, Morris M, Haura E et al. (2006). Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways. J Clin Invest 116: 2208–2217.

    Article  CAS  PubMed Central  Google Scholar 

  • DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK . (2007). Beta-arrestins and cell signaling. Annu Rev Physiol 69: 483–510.

    Article  CAS  Google Scholar 

  • Dredge K, Marriott JB, Macdonald CD, Man HW, Chen R, Muller GW et al. (2002). Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects. Br J Cancer 87: 1166–1172.

    Article  CAS  PubMed Central  Google Scholar 

  • Ebos JM, Tran J, Master Z, Dumont D, Melo JV, Buchdunger E et al. (2002). Imatinib mesylate (STI-571) reduces Bcr-Abl-mediated vascular endothelial growth factor secretion in chronic myelogenous leukemia. Mol Cancer Res 1: 89–95.

    CAS  PubMed  Google Scholar 

  • Ferrara N, Gerber HP, LeCouter J . (2003). The biology of VEGF and its receptors. Nat Med 9: 669–676.

    Article  CAS  Google Scholar 

  • Figg WD . (2006). The 2005 Leon I. Goldberg Young Investigator Award Lecture: development of thalidomide as an angiogenesis inhibitor for the treatment of androgen-independent prostate cancer. Clin Pharmacol Ther 79: 1–8.

    Article  Google Scholar 

  • Folkman J, Merler E, Abernathy C, Williams G . (1971). Isolation of a tumor factor responsible for angiogenesis. J Exp Med 133: 275–288.

    Article  CAS  PubMed Central  Google Scholar 

  • Gavard J, Gutkind JS . (2006). VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 8: 1223–1234.

    Article  CAS  Google Scholar 

  • Ge L, Shenoy SK, Lefkowitz RJ, DeFea K . (2004). Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2. J Biol Chem 279: 55419–55424.

    Article  CAS  Google Scholar 

  • Girnita L, Shenoy SK, Sehat B, Vasilcanu R, Vasilcanu D, Girnita A et al. (2007). Beta-arrestin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression. J Biol Chem 282: 11329–11338.

    Article  CAS  Google Scholar 

  • Holaday JW, Berkowitz BA . (2009). Antiangiogenic drugs: insights into drug development from endostatin, avastin and thalidomide. Mol Interv 9: 157–166.

    Article  CAS  Google Scholar 

  • Kang J, Shi Y, Xiang B, Qu B, Su W, Zhu M et al. (2005). A nuclear function of beta-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcription. Cell 123: 833–847.

    Article  CAS  Google Scholar 

  • Kelly P, Moeller BJ, Juneja J, Booden MA, Der CJ, Daaka Y et al. (2006). The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis. Proc Natl Acad Sci USA 103: 8173–8178.

    Article  CAS  Google Scholar 

  • Kohout TA, Lin FS, Perry SJ, Conner DA, Lefkowitz RJ . (2001). beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. Proc Natl Acad Sci USA 98: 1601–1606.

    CAS  PubMed  Google Scholar 

  • Kvietikova I, Wenger RH, Marti HH, Gassmann M . (1995). The transcription factors ATF-1 and CREB-1 bind constitutively to the hypoxia-inducible factor-1 (HIF-1) DNA recognition site. Nucleic Acids Res 23: 4542–4550.

    Article  CAS  PubMed Central  Google Scholar 

  • Lakshmikanthan V, Zou L, Kim JI, Michal A, Nie Z, Messias NC et al. (2009). Identification of betaArrestin2 as a corepressor of androgen receptor signaling in prostate cancer. Proc Natl Acad Sci USA 106: 9379–9384.

    Article  CAS  Google Scholar 

  • Lal A, Haynes SR, Gorospe M . (2005). Clean western blot signals from immunoprecipitated samples. Mol Cell Probes 19: 385–388.

    Article  CAS  PubMed Central  Google Scholar 

  • Lefkowitz RJ, Rajagopal K, Whalen EJ . (2006). New roles for beta-arrestins in cell signaling: not just for seven-transmembrane receptors. Mol Cell 24: 643–652.

    Article  CAS  Google Scholar 

  • Lefkowitz RJ, Shenoy SK . (2005). Transduction of receptor signals by beta-arrestins. Science 308: 512–517.

    Article  CAS  Google Scholar 

  • Letessier A, Sircoulomb F, Ginestier C, Cervera N, Monville F, Gelsi-Boyer V et al. (2006). Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers. BMC Cancer 6: 245.

    Article  PubMed Central  Google Scholar 

  • Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N . (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306–1309.

    Article  CAS  PubMed Central  Google Scholar 

  • Li TT, Alemayehu M, Aziziyeh AI, Pape C, Pampillo M, Postovit LM et al. (2009). Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells. Mol Cancer Res 7: 1064–1077.

    Article  CAS  Google Scholar 

  • Liu Y, Cox SR, Morita T, Kourembanas S . (1995). Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ Res 77: 638–643.

    Article  CAS  Google Scholar 

  • Ma XJ, Salunga R, Tuggle JT, Gaudet J, Enright E, McQuary P et al. (2003). Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci USA 100: 5974–5979.

    Article  CAS  Google Scholar 

  • Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME et al. (1999). The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271–275.

    Article  CAS  PubMed Central  Google Scholar 

  • Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD et al. (2005). Genes that mediate breast cancer metastasis to lung. Nature 436: 518–524.

    Article  CAS  PubMed Central  Google Scholar 

  • Moeller BJ, Cao Y, Li CY, Dewhirst MW . (2004). Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell 5: 429–441.

    Article  CAS  PubMed Central  Google Scholar 

  • Mythreye K, Blobe GC . (2009). The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42. Proc Natl Acad Sci USA 106: 8221–8226.

    Article  CAS  Google Scholar 

  • Niida A, Smith AD, Imoto S, Aburatani H, Zhang MQ, Akiyama T . (2009). Gene set-based module discovery in the breast cancer transcriptome. BMC Bioinformatics 10: 71.

    Article  PubMed Central  Google Scholar 

  • Raghuwanshi SK, Nasser MW, Chen X, Strieter RM, Richardson RM . (2008). Depletion of beta-arrestin-2 promotes tumor growth and angiogenesis in a murine model of lung cancer. J Immunol 180: 5699–5706.

    Article  CAS  Google Scholar 

  • Rosano L, Cianfrocca R, Masi S, Spinella F, Di Castro V, Biroccio A et al. (2009). Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis. Proc Natl Acad Sci USA 106: 2806–2811.

    Article  CAS  Google Scholar 

  • Scott MG, Le Rouzic E, Perianin A, Pierotti V, Enslen H, Benichou S et al. (2002). Differential nucleocytoplasmic shuttling of beta-arrestins. Characterization of a leucine-rich nuclear export signal in beta-arrestin2. J Biol Chem 277: 37693–37701.

    Article  CAS  Google Scholar 

  • Semenza GL . (2007). Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE 2007: cm8.

    Article  Google Scholar 

  • Shenoy SK, Xiao K, Venkataramanan V, Snyder PM, Freedman NJ, Weissman AM . (2008). Nedd4 mediates agonist-dependent ubiquitination, lysosomal targeting, and degradation of the beta2-adrenergic receptor. J Biol Chem 283: 22166–22176.

    Article  CAS  PubMed Central  Google Scholar 

  • Vacca A, Scavelli C, Montefusco V, Di Pietro G, Neri A, Mattioli M et al. (2005). Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myeloma. J Clin Oncol 23: 5334–5346.

    Article  CAS  Google Scholar 

  • Vlahovic G, Rabbani ZN, Herndon II JE, Dewhirst MW, Vujaskovic Z . (2006). Treatment with Imatinib in NSCLC is associated with decrease of phosphorylated PDGFR-beta and VEGF expression, decrease in interstitial fluid pressure and improvement of oxygenation. Br J Cancer 95: 1013–1019.

    Article  CAS  PubMed Central  Google Scholar 

  • Wang GL, Jiang BH, Rue EA, Semenza GL . (1995). Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92: 5510–5514.

    Article  CAS  PubMed Central  Google Scholar 

  • Wang GL, Semenza GL . (1995). Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270: 1230–1237.

    Article  CAS  PubMed Central  Google Scholar 

  • Wang P, Wu Y, Ge X, Ma L, Pei G . (2003). Subcellular localization of beta-arrestins is determined by their intact N domain and the nuclear export signal at the C terminus. J Biol Chem 278: 11648–11653.

    Article  CAS  Google Scholar 

  • Zou L, Yang R, Chai J, Pei G . (2008). Rapid xenograft tumor progression in beta-arrestin1 transgenic mice due to enhanced tumor angiogenesis. FASEB J 22: 355–364.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful to Dr Lefkowitz for his insightful comments. We thank Ms Vidya Venkat for technical support. We acknowledge grant support from the NIH (HL080525 to SKS and CA40355 to MWD).

Author information

Authors and Affiliations

  1. Department of Medicine, Duke University Medical Center, Durham, NC, USA

    S K Shenoy, S Han & M R Hara

  2. Department of Cell Biology, Duke University Medical Center, Durham, NC, USA

    S K Shenoy & T Oliver

  3. Department of Radiation Oncology, Duke University Medical Center, Durham, NC, USA

    Y L Zhao, Y Cao & M W Dewhirst

Authors
  1. S K Shenoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y L Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M R Hara
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T Oliver
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Y Cao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M W Dewhirst
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S K Shenoy.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shenoy, S., Han, S., Zhao, Y. et al. β-arrestin1 mediates metastatic growth of breast cancer cells by facilitating HIF-1-dependent VEGF expression. Oncogene 31, 282–292 (2012). https://doi.org/10.1038/onc.2011.238

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2011.238

Keywords

This article is cited by

Search

Advanced search

Quick links